About: Combination pharmaceutical therapies for obesity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Combination pharmaceutical therapies for obesity Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Kishore M Gadde & David B. Allison published April 2009 in Expert Opinion on Pharmacotherapy

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2009 (uk) im April 2009 veröffentlichter wissenschaftlicher Artikel (de) article by Kishore M Gadde & David B. Allison published April 2009 in Expert Opinion on Pharmacotherapy (en)
publication date	wds:Q57314317-751147D7-34B5-49FA-AF24-A0D5666B5486
publication date	2009-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57314317-DDA90F72-F6FB-410D-9371-9B12B35F9917
language of work or name	English
cites work	wds:Q57314317-104447A6-892E-4B07-AE06-994C488ADCE7 wds:Q57314317-20A5BC15-1020-4589-A2F0-3523AD264990 wds:Q57314317-2E0BA029-9BD6-48F4-9250-F2FDFDC44BCD wds:Q57314317-43871091-D74D-448D-90AA-479ED8C3204D wds:Q57314317-4C096872-8D5B-4360-9147-BCED5E1D7068 wds:Q57314317-5E95C268-8DCC-4CDE-8380-6C6240A808A7 wds:Q57314317-67E86F7C-721E-4A63-91E0-BE48CD6737D3 wds:Q57314317-70027CD2-28E6-4E1C-8555-F9EA514206A7 wds:Q57314317-738A0427-FCFC-4D2A-82B9-0CECE0A87917 wds:Q57314317-85C227A3-FC38-4FDF-8731-DBA6E13AC25D wds:Q57314317-89925EB2-EBC8-47C9-82CD-95FE7C3088A0 wds:Q57314317-9BBF84F4-08BE-41EE-AEF9-4D613F102971 wds:Q57314317-A66CB098-0620-411D-ABE6-8498F3366020 wds:Q57314317-BD6E36DA-D505-4978-9AF9-A2809189ABF4 wds:Q57314317-C15D9333-180D-4F70-809E-BA0B5E2C1758 wds:Q57314317-CBBFD74C-5FD2-4889-B5A2-849D26A59DD6 wds:Q57314317-D1602EE8-2B1A-4B0A-AC6A-032B785DFBA5 wds:Q57314317-D2F718DD-D8E2-480E-83D4-7ADA97F81345 wds:Q57314317-DB0895AD-DF9C-49C9-9306-44CBC8F11C29 wds:Q57314317-DFA662C4-CFF5-4747-A953-F2016CE9FB01 wds:Q57314317-E533024A-8913-4C89-832F-ACD44D94E46A wds:Q57314317-ECF70E48-525C-48D7-A6A1-A8196DF3DE78 wds:Q57314317-FC98636E-A7D7-4F2F-B077-5FED24772DC6
cites work	Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults Multiple neural systems controlling food intake and body weight Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies National trends in antiobesity medication use. Central nervous system regulation of food intake Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study Long term pharmacotherapy for obesity and overweight: updated meta-analysis. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study Zonisamide for weight loss in obese adults: a randomized controlled trial A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination Rational design of a combination medication for the treatment of obesity Long-term persistence with orlistat and sibutramine in a population-based cohort Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related Risks Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice Bupropion for weight reduction
author name string	wds:Q57314317-8E4D6871-9508-4B3D-A717-8C3F2A7EB304
author name string	Kishore M Gadde
rdfs:label	Combination pharmaceutical therapies for obesity (en) Combination pharmaceutical therapies for obesity (nl)
skos:prefLabel	Combination pharmaceutical therapies for obesity (en) Combination pharmaceutical therapies for obesity (nl)
name	Combination pharmaceutical therapies for obesity (en) Combination pharmaceutical therapies for obesity (nl)
author	wds:Q57314317-7E36DA47-6A5D-416C-999B-17AF2D117DB0
author	David B. Allison
title	wds:Q57314317-613E538E-5C2C-469B-803F-8D7CFE569DBD
title	Combination pharmaceutical therapies for obesity (en)
page(s)	wds:Q57314317-885F4839-6C08-4BB4-A053-1F83AE4D3026
page(s)	921-5
instance of	wds:Q57314317-25794428-247F-43F0-B962-0A316281AA90 wds:Q57314317-e562080a-97d7-4bb7-9b56-6f3ff843c32d
instance of	editorial scholarly article
main subject	wds:Q57314317-dbcd1548-630b-4a75-86ba-71e382c63449
main subject	epidemiology of obesity
PubMed ID	wds:Q57314317-B3AEA220-B88E-4836-ABFB-CF6A7E025736
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19351275
PubMed ID	19351275
published in	wds:Q57314317-564A894D-57C9-491A-96D5-C77494F77CEF
published in	Expert Opinion on Pharmacotherapy
issue	wds:Q57314317-F1451324-5849-4CA3-BE66-1E815B42559E
volume	wds:Q57314317-56893C75-0032-49BC-A3BD-0469B1E40149
issue	6
volume	10
DOI	wds:Q57314317-07D99CCA-3BC8-4BB5-B205-9489F9E24378
DOI	http://dx.doi.org/10.1517/14656560902824152
DOI	10.1517/14656560902824152
PMCID	wds:Q57314317-2EFB5EE4-7552-44DD-8545-1C6A8670E21B
PMCID	4780673
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57314317
is cites work of	Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity Long-term drug treatment for obesity: a systematic and clinical review Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice Pharmacotherapies for obesity: past, current, and future therapies Combinations of drugs in the Treatment of Obesity Combination phentermine/topiramate for obesity treatment in primary care: a review Obesity: Current and potential pharmacotherapeutics and targets Clinical trial success rates of anti-obesity agents: the importance of combination therapies On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination The clinical pharmacology of obesity

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software